Samuel Nkansah Darko

Samuel Nkansah Darko

Auto-generated profile, based on publicly available information

Samuel Nkansah Darko

Department of Molecular Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
POPortia Boakye Okyere
Portia Boakye Okyere
STSampson Twumasi-Ankrah
Sampson Twumasi-Ankrah
SNSam Newton
Sam Newton
SDSamuel Nkansah Darko
Samuel Nkansah Darko
MAMichael Owusu Ansah
Michael Owusu Ansah
EOEllis Owusu-Dabo
Ellis Owusu-Dabo
Background: Typhoid fever, a significant global health problem, demonstrates a multifaceted transmission pattern. Knowledge of the factors driving its transmission is critical for developing effective control strategies and optimizing resource allocation. Objective: This review aimed to comprehensively synthesize evidence on risk factors associated with typhoid fever transmission from 1928 to 2024. Methods: We searched PubMed, Scopus, Google Scholar, and Semantic Scholar databases using keywords related to risk, contributors, determinants, and causes of typhoid fever. We followed a registered protocol to support our search and triangulated the results. Results: Overall, we retrieved 1614 articles, of which 219 were reviewed. Of these, 109 addressed multiple, non–mutually exclusive typhoid fever risk factors. Unsurprisingly, of the total articles reviewed on risk factors, approximately 70.6% (77/109) originated from the Asian continent (51/109, 46.8%) and the African continent (26/109, 23.9%). Half of the articles (55/109, 50.5%) focused on risk factors related to demographic and socioeconomic transmission, while 44% (48/109) of the articles examined foodborne transmission. Additional risk factors included water, sanitation, and hygiene practices: waterborne transmissions (45/109, 41.3%) and sanitation and hygiene practices (34/109, 31.2%), travel-related risk (19/109, 17.4%), antimicrobial use (14/109, 12.8%), climate-related factors (15/109, 13.8%), environment-related factors (9/109, 8.3%), typhoid carriers (11/109, 10.1%), and host-related risk factors (6/109, 5.5%). Conclusions: This review identifies demographic and socioeconomic factors as key drivers of typhoid transmission, underscoring the need for targeted interventions. Strengthening street food regulation in urban Asia and investing in water infrastructure in rural Africa can significantly mitigate risk. Integrating water, sanitation, and hygiene interventions with typhoid vaccines can reduce immediate exposure while enhancing long-term immunity. Prioritizing these strategies in schools and high-risk communities is essential for sustainable typhoid control. Future research should focus on longitudinal studies to assess risk factor causality and vaccine impact, guiding more effective public health interventions.

6 May 2020 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SDSamuel Nkansah Darko
Samuel Nkansah Darko
HHHenry Hanson
Henry Hanson
STSampson Twumasi-Ankrah
Sampson Twumasi-Ankrah
SBSandra Baffour-Awuah
Sandra Baffour-Awuah
PAPriscilla Adjei-Kusi
Priscilla Adjei-Kusi
EOEllis Owusu-Dabo
Ellis Owusu-Dabo
Background: Praziquantel (PZQ) is the standard treatment for Schistosomiasis in sub-Saharan Africa. However, there is evidence suggesting praziquantel treatment failure in Schistosome infections with associated potential renal impairment. The objective of this study was to determine the effect of three monthly doses of 60 mg/kg/day PZQ on schistosome egg count, liver and renal function during the treatment of urinary schistosomiasis in Ghana. Methods: A nested case-control study was designed from a cohort screened for schistosomiasis; 28 schistosomiasis positive cases by microscopy matched with 53 healthy controls by age and gender. The study population was urban dwellers from the Asokwa sub-metropolitan area, Kumasi in Ghana. Participants were within the age range of 6 to 30 years. We assessed Schistosoma haematobium egg counts in urine and its associated impact on liver and renal function at baseline, treatment and post-treatment phases using serum. Results: Of the 28 cases and 53 controls, 78.6% and 81.1% were males respectively. Globulin levels before treatment was higher in cases [36.7 (32.8, 40.1) vrs 30.5 (22.4, 33.8), p = 0.005] at pre-treatment but not at post-treatment [35.8 (31.2, 39.1) vrs 37.4 (29.7, 43.0), p = 0.767]. Estimated cure rate was 42.9, 46.4 and 96.4% after first, second and third dose respectively. Schistosome egg counts dropped significantly (p = 0.001) from before second dose to post-treatment. Similarly, levels of alanine aminotransferase (p = 0.001), aspartate aminotransferase (p = 0.028) and gamma glutamyl transferase (p = 0.001) significantly declined towards post-treatment. Estimated glomerular filtration rate significantly improved from before second dose to post-treatment using both the Chronic Kidney Disease Epidemiology Program (p = 0.001) and 4-variable Modification of Diet in Renal Disease (p = 0.002) equations. Conclusion: Treatment of urinary Schistosoma hematobium infections with a repeated high monthly dose of 60 mg/kg of praziquantel for 3 months is safe and effective.
1

6 April 2025 in Gut Microbes
Verified
Journal Article
Open access
Barbara VerhaarBarbara Verhaar
Barbara Verhaar
ELEva L. van der Linden
Eva L. van der Linden
CHCharles F. Hayfron-Benjamin
Charles F. Hayfron-Benjamin
EOEllis Owusu-Dabo
Ellis Owusu-Dabo
SDSamuel N. Darko
Samuel N. Darko
CACharles Agyemang
Charles Agyemang
Migration is associated with a substantial change in environmental exposures and health outcomes. We aimed to investigate the shift in gut microbiota composition and the associations with cardiometabolic outcomes in the RODAM-Pros cohort spanning multiple research sites across continents. We determined gut microbiota composition of 1,177 Ghanaian participants in rural Ghana, urban Ghana, and Amsterdam, the Netherlands, using 16S rRNA sequencing. We observed a clear gradient in gut microbiota composition and alpha and beta diversity from rural Ghana to urban Ghana, to Amsterdam. We used pairwise XGBoost machine learning classification models to identify which microbes were most distinct between locations in prevalence and abundance. The associations between these microbes and the locations could partly be explained by differences in confounders such as dietary intake. Groups of microbes that emerged or disappeared along the migration axis were associated with cardiometabolic outcomes, including higher body mass index, higher HbA1c and higher diastolic blood pressure. Concluding, we identified associations between a shift in gut microbiota composition and cardiometabolic risk along the migration axis, underscoring the relevance of gut health in the context of migration-associated adverse health outcomes.

5 March 2025 in eClinicalMedicine
Verified
Journal Article
Open access
ELEva L. van der Linden
Eva L. van der Linden
MHMarieke Hoevenaar-Blom
Marieke Hoevenaar-Blom
EBErik Beune
Erik Beune
SDSamuel Nkansah Darko
Samuel Nkansah Darko
SASampson Twumasi Ankrah
Sampson Twumasi Ankrah
Charles AgyemangCharles Agyemang
Charles Agyemang
Longitudinal data on blood pressure changes in sub-Saharan African populations are limited despite a high hypertension burden. This study analysed systolic blood pressure (SBP) change and hypertension incidence among people from Ghana living in rural Ghana, urban Ghana, people from Ghana living in The Netherlands and a Dutch European population living in Amsterdam, The Netherlands. The population-based Research on Obesity and Diabetes among African Migrants Prospective (RODAM-Pros) cohort study included adults aged ≥18 years at baseline (2012-2015) and follow-up (2019-2021) to study cardiovascular risk factors. At both timepoints, blood pressure (BP) was measured using a semiautomated device. Hypertension was defined as having a SBP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg or the use of antihypertensive medication. We compared age-standardised SBP change and hypertension incidence between the geographical locations via linear and Poisson regression analyses, with adjustment for age, follow-up time, education, baseline BP, body mass index, renal function, and diabetes mellitus. The study protocol was approved by the respective ethics committees in Ghana and The Netherlands. Data from 632 people living in rural Ghana, 602 in urban Ghana, 861 Ghanaian, and 2038 Dutch people living in Amsterdam, were analysed (58.3% women, mean age at baseline 46.5 years, follow-up time 6·5 years). SBP increased most in women in rural Ghana (+9.5 mmHg, 95% confidence interval 7·3-11·7 mmHg), compared to +5·7 mmHg (3·6-7·7 mmHg) in urban Ghana, +2·2 mmHg (0·7-3·7 mmHg) in Ghanaian women in Amsterdam and -0·4 mmHg (-1·2 to 0·4 mmHg) in Dutch women. In men, SBP increased +5·5 mmHg (2·6-8·4 mmHg) in rural Ghana, +6·1 mmHg (2·8-9·5 mmHg) in urban Ghana, +2·1 mmHg (0·4-3·8 mmHg) in Ghanaian men in Amsterdam, and +0·3 mmHg (-0·5 to 1·1 mmHg) in Dutch men. Hypertension incidence ranged from 20·7% (95% confidence interval 14·3-29·2%) in men in rural Ghana to 34·2% (23·3-49·1%) in urban Ghana, vs. 27·9% (19·8-38·5%) in Ghanaian men in Amsterdam and 14·5% (11·8-17·6%) in Dutch men. Among women, incidence was 29·0% (23·1-35·9%) in rural Ghana, 27·6% (21·4-35·3%) in urban Ghana, 34·4% (26·0-45·4%) in Ghanaian women in Amsterdam, and 7·2% (5·6-9·2%) in Dutch women. Hypertension incidence rate ratios did not differ across populations, regardless of adjustment for covariates. SBP and hypertension increases were more pronounced in rural and urban Ghana than among migrants from Ghana in The Netherlands, suggesting that urbanisation of cardiovascular risk profile now extends to rural sub-Saharan Africa. European Research Council (grant number 772244).

19 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
POPortia Boakye Okyere
Portia Boakye Okyere
STSampson Twumasi-Ankrah
Sampson Twumasi-Ankrah
SNSam Newton
Sam Newton
SDSamuel Nkansah Darko
Samuel Nkansah Darko
KBKennedy Gyau Boahen
Kennedy Gyau Boahen
EOEllis Owusu-Dabo
Ellis Owusu-Dabo
Background and Aim: Typhoid fever remains a significant global public health concern and ranked among the top ten causes of outpatient illnesses in Ghana from 2020 to 2022. Identifying the risk factors associated with its complications is crucial for reducing mortality. This study aimed to assess the prevalence, types, and risk factors of complications in febrile patients, with a specific focus on typhoid fever in the Ashanti region of Ghana. Method: Clinical data from 238 patients with positive blood cultures, obtained from the surveillance for Severe Typhoid in Africa program between May 2016 and September 2019 were analysed. Statistical reduction techniques were used to identify key variables, and logistic regression identified factors independently associated with typhoid complications. Results: The overall prevalence of complications amongst the febrile patients was 55% (131/238). S. Typhi and non- S. Typhi infections resulted in 38.9% (28/72) and 62% (103/166) complications, respectively. In general, notable complications associated with febrile illnesses included sepsis (23.5%, 56/238), severe anaemia (19.3%, 46/238), gastrointestinal bleeding (3.8%, 9/238), and intestinal perforation (2.5%, 6/238). Typhoid fever contributed to 18.1% (13/72) of sepsis, 8.3% (6/72) of gastrointestinal bleeding, and 5.6% (4/72) each for severe anaemia and intestinal perforation. Mortality rates were 1.4% (1/72) in S. Typhi patients and 2.4% (4/166) in non- S. Typhi patients. Complications were independently associated with a longer duration of illness before hospital visit (AOR 8.6, 95%CI 1.2-64.7, p=0.035) and rural residence (AOR 0.1, 95%CI 0, 0.7, p=0.024). Conclusion: The study highlights a significant burden of complications among febrile patients in Ghana, with typhoid fever as a major concern. Delayed healthcare-seeking behaviour significantly increased the risk of typhoid complications, while the rural residence appeared to be protective. These findings underscore the need for timely diagnosis, prompt treatment, and health education, especially in urban areas. Strengthening preventive strategies, including vaccination, remains essential to reducing typhoid-related complications and mortality.

6 February 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
COChristian Obirikorang
Christian Obirikorang
EAEvans Asamoah Adu
Evans Asamoah Adu
AAAnthony Afum-Adjei Awuah
Anthony Afum-Adjei Awuah
SDSamuel Nkansah Darko
Samuel Nkansah Darko
FGFrank Naku Ghartey
Frank Naku Ghartey
WOWilliam Kwame Boakye Ansah Owiredu
William Kwame Boakye Ansah Owiredu
Aim: To characterize clinically relevant subgroups of patients with type-2 diabetes mellitus (T2DM) based on adiposity, insulin secretion, and resistance indices. Methods: A cross-sectional study was conducted at Eastern Regional Hospital in Ghana from July to October 2021 to investigate long-term patients with T2DM. To select participants, a systematic random sampling method was employed. Demographic data was collected using a structured questionnaire and fasting blood samples were taken to measure glycemic and lipid levels. Blood pressure and adiposity indices were measured during recruitment. The risk of cardiovascular disease (CVD) was defined using Framingham scores and standard low-density lipoprotein thresholds. To analyze the data, k-means clustering algorithms and regression analysis were used. Results: The study identified three groups in female patients according to body mass index, relative fat mass, glycated hemoglobin, and triglyceride-glucose index. These groups included the obesity-related phenotype, the severe insulin resistance phenotype, and the normal weight phenotype with improved insulin resistance. Among male patients with T2DM, two groups were identified, including the obesity-related phenotype with severe insulin resistance and the normal weight phenotype with improved insulin sensitivity. The severe insulin resistance phenotype in female patients was associated with an increased risk of high CVD (OR = 5.34, 95%CI:2.11–13.55) and metabolic syndrome (OR = 7.07; 95%CI:3.24–15.42). Among male patients, the obesity-related phenotype with severe insulin resistance was associated with an increased intermediate (OR = 21.78, 95%CI:4.17–113.78) and a high-risk CVD (OR = 6.84, 95%CI:1.45–32.12). Conclusions: The findings highlight significant cardiometabolic heterogeneity among T2DM patients. The subgroups of T2DM patients characterized by obesity and/or severe insulin resistance with or without poor glycemic control, have increased risk of CVD. This underscores the importance of considering differences in adiposity, insulin secretion, and sensitivity indices when making clinical decisions for patients with T2DM.